I’m not sure of their analysis, but assuming close.
First 6 months $50.4m loss , so $21.1m second
half year. An improvement, but with budgeted $75m
marketing costs and only $1m+ E4 sales in first half.
It appears a turnaround may be underway. I must say
these are disappointing results. Particularly considering
Metrics and Dermatology contribution which I assume
will be much improved.
What great timing on our illustrious CEOs behalf.
Momentum is everything and selling announcement has me wondering whose side he is on. This turkey has to go..
I’m not sure of their analysis, but assuming close.First 6...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.02 |
Change
-0.130(2.52%) |
Mkt cap ! $408.6M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.09 | $5.00 | $262.6K | 52.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1555 | $5.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.02 | 923 | 9 |
View Market Depth
| Last trade - 13.13pm 31/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |